StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our […]